Société Novartis AG OTC Markets

Société Novartis AG OTC Markets

NVSEF

CH0012005267

Produits pharmaceutiques

Consensus des Analystes

Actions

NVSEF

CH0012005267

Produits pharmaceutiques

Consensus des Analystes

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par activité

Ventes par région

Notations pour Novartis AG

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par activité

Ventes par région

Notations pour Novartis AG

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Temps Différé OTC Markets Autres places de cotation 15:30:45 17/07/2024			Varia. 5j.	Varia. 1 janv.
110 ^USD	+0,40 %		+2,46 %	+10,00 %

14:01	Prévisions Novartis: recettes de 12,3 milliards de dollars au 2e partiel	AW
16/07	Bourse Zurich: dans le rouge, prudence de mise avant la BCE	AW

Novartis AG figure parmi les leaders mondiaux de la conception, de la fabrication et de la commercialisation de produits pharmaceutiques. Le CA (hors activités abandonnées) par domaine thérapeutique se répartit comme suit :

- oncologie (29,9%) ;

- immunologie (17,2%) ;

- maladies cardio-vasculaires, rénales et métaboliques (14,1%) ;

- neuroscience (8,9%) ;

Le solde du CA (29,9%) concerne l'activité de fabrication en sous-traitance de produits pharmaceutiques.

A fin 2023, Novartis AG dispose de 33 sites de production dans le monde.

La répartition géographique du CA est la suivante : Europe (33%), Etats-Unis (39,5%), Asie-Afrique-Australasie (20,5%), Canada et Amérique latine (7%).

Nombre d'employés: 76 057

CHF en Millions	2022	Poids	2023	Poids	Delta
Established Brands 30,0 %	-	-	12 238	30,0 %	-
Oncology 29,9 %	-	-	12 213	29,9 %	-
Immunology 17,2 %	-	-	7 008	17,2 %	-
Cardiovascular, Renal and Metabolic 14,1 %	-	-	5 743	14,1 %	-
Neuroscience 8,9 %	-	-	3 633	8,9 %	-

CHF en Millions	2022	Poids	2023	Poids	Delta
United States 39,5 %	16 860	34,9 %	16 139	39,5 %	-4,28 %
Europe 18,9 %	10 469	21,7 %	7 704	18,9 %	-26,41 %
Asia/Africa/Australasia 9,1 %	4 975	10,3 %	3 700	9,1 %	-25,63 %
Germany 7,4 %	4 086	8,5 %	3 026	7,4 %	-25,94 %
China 7,2 %	2 987	6,2 %	2 936	7,2 %	-1,73 %
Canada and Latin America 7,0 %	3 709	7,7 %	2 854	7,0 %	-23,04 %
Japan 4,2 %	2 106	4,4 %	1 729	4,2 %	-17,90 %
France 3,8 %	2 156	4,5 %	1 572	3,8 %	-27,09 %
Switzerland 2,9 %	926	1,9 %	1 175	2,9 %	+26,88 %

Dirigeants	Titre	Age	Depuis
Vasant Narasimhan CEO	Chief Executive Officer	48	01/01/05
Harry Werner Kirsch DFI	Director of Finance/CFO	59	01/01/03
Shreeram Aradhye CTO	Chief Tech/Sci/R&D Officer	62	16/05/22
Steffen Lang COO	Chief Operating Officer	57	01/04/17
Klaus Moosmayer CMP	Compliance Officer	56	01/12/18
Samir Shah IRO	Public Communications Contact	63	01/01/04
Simon Brown PRN	Corporate Officer/Principal	-	01/08/13
Kees Roks AUD	Comptroller/Controller/Auditor	61	01/05/22
Linda Kanitra PRN	Corporate Officer/Principal	-	-
Robert Kowalski HRO	Human Resources Officer	56	01/09/21

Administrateurs	Titre	Age	Depuis
Bill Winters BRD	Director/Board Member	62	01/01/13
Simon Moroney BRD	Director/Board Member	65	28/02/20
Hans Jörg Reinhardt CHM	Chairman	68	01/01/13
John Young BRD	Director/Board Member	60	07/03/23
Bridgette Heller BRD	Director/Board Member	62	28/02/20
Ton Büchner BRD	Director/Board Member	59	01/01/16
Charles Sawyers BRD	Director/Board Member	65	01/01/13
Nancy Andrews BRD	Director/Board Member	65	01/01/15
Patrice Bula BRD	Director/Board Member	68	28/02/19
Frans van Houten BRD	Director/Board Member	64	28/02/17

	Vote	Nombre	Flottant	Autocontrôle	Flottant Total
Action A	1	2 189 930 497	1 866 336 959 ( 85,22 %)	233 443 766 ( 10,66 %)	85,22 %

Nom	Actions	%	Valorisation
NOVARTIS AG 6,625 %	145 083 991	6,625 %	15 527 M $
Sandoz Family Foundation 4,070 %	89 135 960	4,070 %	9 540 M $
UBS Asset Management Switzerland AG 3,123 %	68 391 910	3,123 %	7 319 M $
State Street Global Advisors Ltd. 0,2196 %	4 809 474	0,2196 %	515 M $
MFS International Singapore Pte Ltd. 0,1917 %	4 198 717	0,1917 %	449 M $
Sjunde AP-fonden 0,1384 %	3 031 826	0,1384 %	324 M $
Eleva Capital LLP 0,1355 %	2 967 691	0,1355 %	318 M $
MFS International (UK) Ltd. 0,1342 %	2 938 481	0,1342 %	314 M $
Barings (UK) Ltd. 0,1310 %	2 868 212	0,1310 %	307 M $
Amundi Asset Management SA (Investment Management) 0,1084 %	2 373 632	0,1084 %	254 M $

Nom	Actions	%	Valorisation
PRIMECAP Management Co. 0,5670 %	12 417 755	0,5670 %	1 322 M $
Dodge & Cox 0,5641 %	12 353 985	0,5641 %	1 315 M $
Eaton Vance Management 0,3314 %	7 258 381	0,3314 %	773 M $
Loomis, Sayles & Co. LP 0,2702 %	5 917 972	0,2702 %	630 M $
DFA Australia Ltd. 0,2625 %	5 748 542	0,2625 %	612 M $
Fiduciary Trust Company International 0,2603 %	5 699 789	0,2603 %	607 M $
U.S. Trust Company of Delaware 0,2273 %	4 977 839	0,2273 %	530 M $
Wellington Trust Co., NA 0,2096 %	4 589 350	0,2096 %	489 M $
Wells Fargo Bank NA 0,1826 %	3 997 877	0,1826 %	426 M $
The Ayco Co. LP 0,1397 %	3 059 361	0,1397 %	326 M $

Nom	Actions	%	Valorisation
LUKB Expert Fondsleitung AG -	64 694	-	7 M $
Swiss Rock Asset Management AG -	19 614	-	2 M $

Nom	Actions	%	Valorisation
NOVARTIS AG 6,63%	145 083 991	6,63%	15 527 183 237 $
MORPHOSYS AG 51,00%	19 235 376	51,00%	1 393 608 762 $
SANDOZ GROUP AG 2,99%	12 886 900	2,99%	466 659 005 $
NOVARTIS INDIA LIMITED 70,68%	17 450 680	70,68%	231 036 358 $
THIRD HARMONIC BIO, INC. 6,45%	2 642 762	6,45%	34 355 906 $
ERASCA, INC. 4,74%	12 307 692	4,74%	29 046 153 $
OCULIS HOLDING AG 4,11%	1 713 521	4,11%	20 476 576 $
MOLECULAR PARTNERS AG 4,74%	1 739 130	4,74%	12 618 658 $
PRECISION BIOSCIENCES, INC. 5,97%	413 581	5,97%	4 024 143 $

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com

Nom	Catégorie et Secteur
Novartis Healthcare Pvt Ltd. Novartis Healthcare Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar.	Pharmaceuticals: Major
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis Investment Ltd.
Novartis Holding AG Novartis Holding AG Financial ConglomeratesFinance Part of Novartis AG, Novartis Holding AG is a Swiss healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Basel, Switzerland. Novartis Holding specializes in Managed Access Programs and is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment.	Financial Conglomerates
Novartis International AG Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis Services, Inc.
Novartis Finance SA	Finance/Rental/Leasing
Novartis BioVenturesAG Novartis BioVenturesAG Investment ManagersFinance Part of Novartis AG, Novartis BioVenturesAG is an alternative investment manager. The company is based in Basel, Switzerland.	Investment Managers
Novartis Investments SARL Novartis Investments SARL Financial ConglomeratesFinance Novartis Investments SARL is an investment holding company with interest in medicines and pharmaceuticals sector. The company was founded on July 05, 2002 and is headquartered in Luxembourg.	Financial Conglomerates
Novartis Securities Investment Ltd. Novartis Securities Investment Ltd. Investment ManagersFinance Part of Novartis AG, Novartis Securities Investment Ltd. is an investment bank that offers investment advice. The company is located in Bermuda.	Investment Managers
Novartis Capital Corp. Novartis Capital Corp. Finance/Rental/LeasingFinance Novartis Capital Corp. engages in the manufacture of pharmaceutical products. The company is headquartered in East Hanover, NJ.	Finance/Rental/Leasing
Sandoz Pvt Ltd. Sandoz Pvt Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz Pvt Ltd. is an Indian company that develops, manufactures, and markets generic pharmaceutical products. The company is based in Mumbai, India. Sandoz was founded in 1995.	Pharmaceuticals: Generic
Novartis Investment Ltd. (2120)
Novartis Pharma GmbH Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.	Pharmaceuticals: Major
Sandoz GmbH Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.	Pharmaceuticals: Major
Alcon Ophthalmika GmbH
EBEWE Pharma Ges.m.b.H. Nfg.KG EBEWE Pharma Ges.m.b.H. Nfg.KG Pharmaceuticals: MajorHealth Technology EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria.	Pharmaceuticals: Major
NOVARTIS INDIA LIMITED	Pharmaceuticals: Major
Novartis UK Pension Scheme	Investment Managers

Note Trading

Note Investissement

ESG Refinitiv

Plus de notations

Vente

Achat

Recommandation moyenne

ACCUMULER

Nombre d'Analystes

Dernier Cours de Cloture

110,4 USD

Objectif de cours Moyen

112,7 USD

Ecart / Objectif Moyen

+2,06 %

Consensus

Révisions des Estimations

Agenda de la société

	Varia. 1 janv.	Capi.
ELI LILLY AND COMPANY	+57,33 %	848 Md
NOVO NORDISK A/S	+31,64 %	627 Md
JOHNSON & JOHNSON	-0,77 %	363 Md
MERCK & CO., INC.	+15,01 %	318 Md
ABBVIE INC.	+12,20 %	299 Md
ASTRAZENECA PLC	+15,43 %	243 Md
AMGEN INC.	+15,87 %	179 Md
PFIZER, INC.	+3,40 %	167 Md
SANOFI	+2,52 %	125 Md

Pharmacies - Autres

Recherche pharmaceutique et médicale

Produits pharmaceutiques

Produits pharmaceutiques

Pharmacies - Autres